albicans , including Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs)
these agents now form an essential part of the armamentarium for appropriate cardio-metabolic risk management in T2DM [7]
Besides all these differences, their effect on glycemic control and T2DM prognosis remains elusive
Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide acts on both GIP and GLP-1 receptors, creating a dual mechanism that produces greater weight loss but also a distinct side effect profile
In oncology, there's potential for it to target senescent cells within the tumor microenvironment, possibly impeding cancer progression and metastasis
As an incretin hormone, it stimulates insulin synthesis and secretion in the pancreas via PKA and exchange protein directly activated by cAMP signaling pathways, thereby enhancing glucose metabolism (40-42)